Eyevance Pharmaceuticals appoints chief commercial officer

Eyevance Pharmaceuticals added Julie Speed to its executive team as the chief commercial officer, onboarding a leader with more than 21 years of experience.

Advertisement

What you should know:

1. Ms. Speed will develop a commercial strategy for the company’s Eyevance product portfolio.

2. She comes to Eyevance from Johnson & Johnson Vision where she most recently served as senior director of U.S. marketing.

3. Ms. Speed has a storied career, including tenures at TearLab Corp., and Alcon.

She commented on Eyevance’s portfolio, saying, “Eyevance’s robust product pipeline of commercial and development-stage assets have the opportunity to address many unmet ophthalmic market needs, which will position the organization for sustained success in 2020 and beyond.”

More articles on surgery centers:
ASC supply chain tip of the day: Prepare for shortages
3 recent updates on Medline
6 ASC supply chain tips
 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.